The Trump border wall was one of the most iconic and controversial promises of Donald Trump’s 2016 presidential campaign.

Police in Juarez, Mexico, have pulled three bodies from clandestine graves not far from an area near the Rio Grande where ...

Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.

YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3 - TransCon CNP NDA submission for achondroplasia planned for Q1 2025 ...